COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

EPA:COVH • FR0000060303

22.7 EUR
-0.1 (-0.44%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 43 industry peers in the Diversified REITs industry. Both the profitability and the financial health of COVH get a neutral evaluation. Nothing too spectacular is happening here. COVH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year COVH was profitable.
  • In the past year COVH had a positive cash flow from operations.
  • Of the past 5 years COVH 4 years were profitable.
  • Of the past 5 years COVH 4 years had a positive operating cash flow.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • COVH has a Return On Assets of 2.89%. This is in the better half of the industry: COVH outperforms 65.12% of its industry peers.
  • COVH has a Return On Equity of 5.88%. This is in the better half of the industry: COVH outperforms 62.79% of its industry peers.
  • COVH has a Return On Invested Capital (3.68%) which is in line with its industry peers.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • COVH has a Profit Margin of 78.96%. This is amongst the best in the industry. COVH outperforms 88.37% of its industry peers.
  • COVH's Profit Margin has declined in the last couple of years.
  • COVH has a Operating Margin of 101.55%. This is amongst the best in the industry. COVH outperforms 97.67% of its industry peers.
  • COVH's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y0.45%
OM growth 5Y15.26%
PM growth 3Y-12.76%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for COVH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • COVH has an Altman-Z score of 1.02. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of COVH (1.02) is better than 67.44% of its industry peers.
  • The Debt to FCF ratio of COVH is 12.71, which is on the high side as it means it would take COVH, 12.71 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of COVH (12.71) is comparable to the rest of the industry.
  • COVH has a Debt/Equity ratio of 0.70. This is a neutral value indicating COVH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.70, COVH is in line with its industry, outperforming 51.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.02
ROIC/WACC0.69
WACC5.37%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of COVH (1.16) is better than 81.40% of its industry peers.
  • COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of COVH (1.16) is better than 83.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.96% over the past year.
  • The earnings per share for COVH have been decreasing by -15.51% on average. This is quite bad
  • The Revenue for COVH has decreased by -15.46% in the past year. This is quite bad
  • The Revenue has been growing by 8.97% on average over the past years. This is quite good.
EPS 1Y (TTM)25.96%
EPS 3Y-15.51%
EPS 5YN/A
EPS Q2Q%86.66%
Revenue 1Y (TTM)-15.46%
Revenue growth 3Y-1.04%
Revenue growth 5Y8.97%
Sales Q2Q%-17.84%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.88 indicates a reasonable valuation of COVH.
  • Based on the Price/Earnings ratio, COVH is valued a bit cheaper than the industry average as 72.09% of the companies are valued more expensively.
  • COVH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.83.
  • COVH is valuated correctly with a Price/Forward Earnings ratio of 13.17.
  • COVH's Price/Forward Earnings is on the same level as the industry average.
  • COVH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 11.88
Fwd PE 13.17
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, COVH is valued a bit cheaper than the industry average as 69.77% of the companies are valued more expensively.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as COVH.
Industry RankSector Rank
P/FCF 15.5
EV/EBITDA 16.78
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.55%, COVH is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 5.12, COVH pays a bit more dividend than its industry peers.
  • COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.55%

5.2 History

  • The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • COVH pays out 19.15% of its income as dividend. This is a sustainable payout ratio.
  • The Dividend Rate of COVH has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP19.15%
EPS Next 2YN/A
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVIVIO HOTELS SACA

EPA:COVH (3/3/2026, 7:00:00 PM)

22.7

-0.1 (-0.44%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-16
Earnings (Next)07-14
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.59B
Revenue(TTM)235.20M
Net Income(TTM)205.77M
Analysts82.86
Price Target18.67 (-17.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.55%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.15%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE 13.17
P/S 13.76
P/FCF 15.5
P/OCF 9.8
P/B 1.03
P/tB 1.13
EV/EBITDA 16.78
EPS(TTM)1.91
EY8.41%
EPS(NY)1.72
Fwd EY7.59%
FCF(TTM)1.46
FCFY6.45%
OCF(TTM)2.32
OCFY10.2%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.85
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.45%
OM growth 5Y15.26%
PM growth 3Y-12.76%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.95
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.12
Cash Conversion 103.44%
Profit Quality 112.46%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.02
F-Score6
WACC5.37%
ROIC/WACC0.69
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.96%
EPS 3Y-15.51%
EPS 5YN/A
EPS Q2Q%86.66%
EPS Next Y-1.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.46%
Revenue growth 3Y-1.04%
Revenue growth 5Y8.97%
Sales Q2Q%-17.84%
Revenue Next Year2.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y-0.59%
EBIT growth 5Y25.59%
EBIT Next Year-5.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.31%
OCF growth 3YN/A
OCF growth 5YN/A

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Fairly Valued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 11.88 and the Price/Book (PB) ratio is 1.03.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to decline by -1.17% in the next year.